Business
PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology
PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has executed a non-binding letter of intent with Duke University to license, through a newly-formed subsidiary, Duke's technology to identify and facilitate treatment of advanced esophageal precancer (dysplasia) during upper endoscopy. This technology—a multi-modality probe combining an
About this update from Duke Energy Corporation (holding Company)
[{"type":"text","content":"Newly-formed PAVmed subsidiary to license endoscopic imaging technology designed to identify and facilitate ablative treatment of esophageal dysplasia","length":150,"tagName":"p","attribs":{}},{"type":"text","content":"Lucid Diagnostics to collaborate with PAVmed as a strategic and equity partner on the technology","length":96,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, Aug. 26, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has executed a non-binding letter of intent with Duke University to license, through a newly-formed subsidiary, Duke's technology to identify and facilitate treatment of advanced esophageal precancer (dysplasia) during upper endoscopy. This technology—a multi-modality probe combining angle-resolved low coherence interferometry (a/LCI) with optical coherence tomography (OCT)—could allow for a more efficient and effective alternative to traditional biopsies.","length":753,"tagName":"p"},{"type":"image","alt":"PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. (PRNewsfoto/PAVmed Inc.)","displaySize":"","headline":null,"caption":"PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. (PRNewsfoto/PAVmed Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":81,"url":"https://media.zenfs.com/en/prnewswire.com/b33818e0ad32f6b512ca93166f23ff80"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_9ksw7DB5omdDmUMhUY16g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b33818e0ad32f6b512ca93166f23ff80","width":400,"height":81}},"href":"https://mma.prnewswire.com/media/2011714/PAVmed_updated_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""This groundbreaking technology has the potential to fundamentally transform how we diagnose and treat esophageal precancer, while simultaneously improving patient outcomes, procedural efficiency, and healthcare resource utilization," said Nic...